From Nasdaq:

1. TC Biopharm (Holdings) Plc. has announced plans to lay off 50% of its workers in an effort to reduce costs and expand its cash runway.

2. The company will focus research and development efforts solely on the development of commercial applications and manufacturing.

3. TC Biopharm (Holdings) Plc. expects these measures to help complete the ACHIEVE trial by 2024.

4. In pre-market activity, the company’s stock climbed by 2.19% to $3.1984 on the Nasdaq.



Read more: TC BioPharm To Reduce Headcount By 50%